Tag Archives: Covers

Lemtrada Review By European Drug Regulatory Agency Covers Various Serious Side Effects In MS Patients

Points Out New Reports Of Conditions Beyond Those That Were Covered In November 2018 FDA Drug Safety Communication   (Posted by Tom Lamb at DrugInjuryWatch.com)   We recently learned by means of this April 12, 2019 European Medicines Agency (EMA) … Continue reading

Posted in Health Law | Tagged , , , , , , , , , , , | Leave a comment

Don’t Assume Your Insurance Covers A Newly Acquired Company

The Supreme Court of Virginia’s decision yesterday finding no coverage for fire damage to a building is a cautionary tale for companies acquiring other companies. Erie Ins. Exch. v. EPC MD 15, LLC, 2019 WL 238168 (Va. Jan. 17, 2019). … Continue reading

Posted in Insurance | Tagged , , , , , , | Leave a comment

Blockchain Goes Wall Street – New Issued Patent Covers Cryptocurrency Trading Platform

With bitcoin prices rising from the dead over the last few weeks (up nearly 25% from a December 14 low), there’s a degree of renewed excitement regarding blockchain and cryptocurrency. But as general public interest rises and falls, the steady … Continue reading

Posted in Technology & Cyberlaw | Tagged , , , , , , , , , | Leave a comment

The 75 Best Book Covers of 2018 According to Book Cover Designers

Literary Hub: “2018 has been many things, but it certainly has not been lacking in great book cover design. Here at Lit Hub, we unpacked the biggest book cover trend of the year, compared US covers to their UK counterparts, and … Continue reading

Posted in Legal Marketing | Tagged , , , , , , | Leave a comment

Lanham Act covers ads that drug is FDA-approved/has ANDA

Arbor Pharmaceuticals, LLC v. ANI Pharmaceuticals, Inc., 2018 WL 3677923, No. 17-4910 (D. Minn. Aug. 2, 2018)Arbor sells prescription erythromycin ethylsuccinate for oral suspension, allegedly the only FDA-approved products of their kind on the market. ANI announced the launch of … Continue reading

Posted in Advertising Law | Tagged , , , , | Leave a comment